The Agency for Healthcare Research and Quality (AHRQ) recently identified the perioperative administration of beta-blockers as one of 11 specific practices with sufficient clinical-based evidence for patient safety to justify…
Special Article: Sleep Apnea and Narcotic Postoperative Pain Medication: A Morbidity and Mortality Risk
Sleep apnea has long been a concern for anesthesiologists because of its association with difficult intubation and recovery room complications. Claim reviews at The Doctors Company (TDC) have revealed a…
The Anesthesia Patient Safety Foundation Newsletter is the official publication of the nonprofit Anesthesia Patient Safety Foundation and is published quarterly at Wilmington, Delaware. Annual membership: Individual – $25.00, Corporate – $500.00. This and any additional contributions to the Foundation are tax deductible. © Copyright, Anesthesia Patient Safety Foundation, 2002.
The opinions expressed in this Newsletter are not necessarily those of the Anesthesia Patient Safety Foundation or its members or board of directors. Validity of opinions presented, drug dosages, accuracy, and completeness of content are not guaranteed by the APSF.
APSF Executive Committee:
Robert K. Stoelting, MD, President; Burton A. Dole, Jr., Vice-President; David M. Gaba, MD, Secretary; Casey D. Blitt, MD, Treasurer; Ellison C. Pierce, Jr., MD, Executive Director; Robert A. Caplan, MD; Jeffrey B. Cooper, PhD; Lori Cross; John H. Eichhorn, MD.
Newsletter Editorial Board:
Robert C. Morell, MD, Editor; Sorin Brull, MD; Joan Christie, MD; Jan Ehrenwerth, MD; John H. Eichhorn, MD; Denise O’Brien, BSN, RN; Karen Posner, PhD; Keith Ruskin, MD; Wilson Somerville, PhD; Jeffery Vender, MD.